Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Here's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings
Motley Fool
Tuesday, July 22, 2014 - 11:45am
tags:
AbbVie, GSK, earnings
Roche CEO: No appetite for expensive megadeals here
Fierce Pharma
Tuesday, July 22, 2014 - 9:54am
tags:
Pharma CEOs, Roche, Severin Schwan, M&A
JAMA: Hep C drugs could add $300 to every American's insurance premium
Fierce Pharma
Tuesday, July 22, 2014 - 9:51am
tags:
insurance, hepatitis C, Sovaldi
Allergan stand alone value now above Valeant offer, says Bernstein
The Fly on the Wall
Tuesday, July 22, 2014 - 9:00am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Actelion Raises Full-Year Profit Forecast on Opsumit
Bloomberg
Tuesday, July 22, 2014 - 8:58am
tags:
Actelion, Opsumit, Tracleer, earnings
Thermo Fisher Wins 3 Oscars of Innovation, Shares Rise
Yahoo/Zacks.com
Tuesday, July 22, 2014 - 8:56am
tags:
Thermo Fisher
Alkermes' Pipeline Development Impresses, Key Updates Ahead
Yahoo/Reuters
Tuesday, July 22, 2014 - 8:54am
tags:
Alkermes, Invega Sustenna, ALKS 3831, aripiprazole lauroxil, ALKS 5461
Celgene drug can drive HIV out of hiding -study
Yahoo/Reuters
Tuesday, July 22, 2014 - 8:50am
tags:
HIV, Celgene, romidepsin, AIDS
Kindred says prepared to raise offer for Gentiva
Yahoo/Reuters
Tuesday, July 22, 2014 - 8:48am
tags:
Kindred Healthcare, Gentiva Health Services, M&A
Drugmakers to share neglected compounds with British academia
Yahoo/Reuters
Tuesday, July 22, 2014 - 8:47am
tags:
UK, R&D, AstraZeneca, GSK, JNJ, Eli Lilly, Pfizer, Takeda, UCB Pharmaceuticals
Bad Times Continue To Hit Merck's Animal Health Segment
Seeking Alpha
Tuesday, July 22, 2014 - 8:43am
tags:
Zilmax, Merck Animal Health, animal health, Merck, Zoetis, Pfizer, Eli Lilly
Johnson & Johnson sets $5 billion share buyback
Marketwatch
Tuesday, July 22, 2014 - 8:37am
tags:
JNJ, share repurchase
Abbvie’s $8 billion in tax breaks from Shire deal may come just in time
Marketwatch
Tuesday, July 22, 2014 - 8:36am
tags:
AbbVie, Shire, tax inversions, M&A, Humira
How Much Will Those Allergan Cost Cuts Really Help? Read Here
WSJ Online
Monday, July 21, 2014 - 3:42pm
tags:
Allergan, restructuring, M&A, Valeant Pharmaceuticals
Sequenom VisibiliT launch unlikely to have near-term impact, says Ladenburg
Yahoo/Fly on the Wall
Monday, July 21, 2014 - 3:41pm
tags:
Sequenom, VisibiliT, diagnostics
Amgen's AMG 416 Succeeds in Phase III, Shares Up
Yahoo/Zacks.com
Monday, July 21, 2014 - 3:38pm
tags:
Amgen, AMG 416, kidney disease
ABBV, MRK And PFE, Pushing Health Care Sector Downward
TheStreet.com
Monday, July 21, 2014 - 3:34pm
tags:
AbbVie, Merck, Pfizer
Gilead Sciences: Sovaldi’s a Blockbuster, the Question is How Big
Barron's
Monday, July 21, 2014 - 11:01am
tags:
Gilead Sciences, Sovaldi, hepatitis C
Monday’s Top Biotech Stories: Allergan, Anacor, and Sinovac Biotech
Motley Fool
Monday, July 21, 2014 - 10:43am
tags:
Allergan, layoffs, Anacor, Sinovac Biotech, Kerydin, earnings, China, Sandoz, vaccines
Swiss hearing loss firm Auris Medical to raise up to $95 million in US IPO
Reuters
Monday, July 21, 2014 - 10:39am
tags:
IPOs, Auris Medical, hearing loss

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.